Marissa Brittenham - 05 Mar 2026 Form 4 Insider Report for Surgery Partners, Inc. (SGRY)

Role
Chief Strategy Officer
Signature
/s/ Jennifer Baldock, Attorney-in-Fact
Issuer symbol
SGRY
Transactions as of
05 Mar 2026
Net transactions value
-$120,354
Form type
4
Filing time
09 Mar 2026, 19:32:51 UTC
Previous filing
13 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Brittenham Marissa Chief Strategy Officer C/O SURGERY PARTNERS, INC., 340 SEVEN SPRINGS WAY, SUITE 600, BRENTWOOD /s/ Jennifer Baldock, Attorney-in-Fact 09 Mar 2026 0001908044

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGRY Common Stock Sale $120,354 -8,785 -14% $13.70 54,623 06 Mar 2026 Direct F1
transaction SGRY Common Stock Award +17,717 +32% $14.11* 72,340 05 Mar 2026 Direct F2
transaction SGRY Common Stock Award +16,363 +23% $14.11* 88,703 05 Mar 2026 Direct F3
transaction SGRY Common Stock Award +9,150 +10% $14.11* 97,853 05 Mar 2026 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2026 and March 2, 2026.
F2 Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date.
F3 Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date.
F4 Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the second anniversary of the Grant Date.